Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronavirus Infections | 3 | 2014 | 304 | 0.940 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2014 | 88 | 0.900 |
Why?
|
| Immunotherapy | 2 | 2019 | 692 | 0.870 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 154 | 0.680 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 137 | 0.640 |
Why?
|
| Cancer Vaccines | 1 | 2019 | 160 | 0.610 |
Why?
|
| beta Catenin | 1 | 2019 | 267 | 0.600 |
Why?
|
| Murine hepatitis virus | 2 | 2014 | 7 | 0.590 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 202 | 0.570 |
Why?
|
| T-Lymphocytes | 3 | 2022 | 1226 | 0.550 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 618 | 0.520 |
Why?
|
| Melanoma | 1 | 2019 | 470 | 0.500 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 470 | 0.480 |
Why?
|
| Rodent Diseases | 1 | 2014 | 34 | 0.470 |
Why?
|
| Coronavirus | 1 | 2014 | 18 | 0.460 |
Why?
|
| Antigens, Viral | 1 | 2014 | 145 | 0.450 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2014 | 596 | 0.440 |
Why?
|
| Antigen Presentation | 1 | 2014 | 215 | 0.430 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 47 | 0.420 |
Why?
|
| Peptides | 1 | 2014 | 649 | 0.360 |
Why?
|
| Neoplasms | 2 | 2022 | 3080 | 0.280 |
Why?
|
| Inflammation | 1 | 2012 | 972 | 0.280 |
Why?
|
| Brain | 2 | 2014 | 2289 | 0.260 |
Why?
|
| Extracellular Traps | 1 | 2022 | 12 | 0.210 |
Why?
|
| Mice | 6 | 2022 | 11807 | 0.210 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2022 | 173 | 0.200 |
Why?
|
| Histiocytes | 1 | 2021 | 22 | 0.190 |
Why?
|
| Antigens, CD19 | 1 | 2021 | 43 | 0.190 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2021 | 51 | 0.190 |
Why?
|
| Viral Proteins | 2 | 2014 | 301 | 0.180 |
Why?
|
| Saliva | 1 | 2021 | 124 | 0.180 |
Why?
|
| Fever | 1 | 2020 | 128 | 0.170 |
Why?
|
| Thrombosis | 1 | 2022 | 302 | 0.170 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 192 | 0.170 |
Why?
|
| Ipilimumab | 1 | 2019 | 62 | 0.170 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 194 | 0.170 |
Why?
|
| CTLA-4 Antigen | 1 | 2019 | 140 | 0.160 |
Why?
|
| Interleukin-12 | 1 | 2019 | 111 | 0.160 |
Why?
|
| Monodelphis | 2 | 2009 | 3 | 0.160 |
Why?
|
| Immunomodulation | 1 | 2018 | 58 | 0.160 |
Why?
|
| Adoptive Transfer | 1 | 2018 | 169 | 0.150 |
Why?
|
| Animals | 7 | 2022 | 27445 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 3229 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 487 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.130 |
Why?
|
| Humans | 11 | 2022 | 89675 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 972 | 0.120 |
Why?
|
| Transcriptome | 1 | 2019 | 637 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1720 | 0.120 |
Why?
|
| Glutathione | 1 | 2014 | 108 | 0.120 |
Why?
|
| Cysteine | 1 | 2014 | 137 | 0.110 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 388 | 0.110 |
Why?
|
| Amino Acid Substitution | 1 | 2014 | 338 | 0.110 |
Why?
|
| B7-2 Antigen | 1 | 2012 | 40 | 0.110 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2014 | 201 | 0.110 |
Why?
|
| HeLa Cells | 1 | 2014 | 512 | 0.110 |
Why?
|
| CD40 Antigens | 1 | 2012 | 45 | 0.110 |
Why?
|
| Macrophage Activation | 1 | 2012 | 49 | 0.110 |
Why?
|
| Mutation, Missense | 1 | 2014 | 280 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2012 | 165 | 0.100 |
Why?
|
| Microglia | 1 | 2012 | 108 | 0.100 |
Why?
|
| Biomarkers | 1 | 2018 | 1771 | 0.100 |
Why?
|
| Doxorubicin | 1 | 2012 | 303 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 171 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2012 | 279 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 446 | 0.080 |
Why?
|
| Macrophages | 1 | 2012 | 574 | 0.080 |
Why?
|
| Male | 5 | 2021 | 42581 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 1577 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2019 | 3398 | 0.080 |
Why?
|
| Virus Replication | 1 | 2010 | 326 | 0.080 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2008 | 10 | 0.080 |
Why?
|
| Thymus Gland | 1 | 2009 | 197 | 0.070 |
Why?
|
| Young Adult | 1 | 2019 | 6350 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2009 | 524 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2010 | 675 | 0.070 |
Why?
|
| Recombination, Genetic | 1 | 2009 | 445 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2009 | 394 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2022 | 1848 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 1160 | 0.060 |
Why?
|
| Middle Aged | 2 | 2021 | 26086 | 0.060 |
Why?
|
| Adult | 2 | 2021 | 26708 | 0.060 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2022 | 31 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 43 | 0.050 |
Why?
|
| Adrenal Insufficiency | 1 | 2022 | 23 | 0.050 |
Why?
|
| Angiotensin II | 1 | 2022 | 93 | 0.050 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 55 | 0.050 |
Why?
|
| Genomics | 1 | 2008 | 777 | 0.050 |
Why?
|
| Epitopes | 1 | 2022 | 255 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 67 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2022 | 171 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2008 | 848 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2022 | 178 | 0.050 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2021 | 39 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2022 | 268 | 0.050 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2020 | 17 | 0.050 |
Why?
|
| Viral Load | 1 | 2021 | 145 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 309 | 0.040 |
Why?
|
| Female | 4 | 2021 | 46391 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 282 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2021 | 318 | 0.040 |
Why?
|
| Drug Monitoring | 1 | 2020 | 119 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 276 | 0.040 |
Why?
|
| Informed Consent | 1 | 2022 | 276 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 887 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2022 | 550 | 0.040 |
Why?
|
| Protein Binding | 1 | 2022 | 1490 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2022 | 901 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2022 | 858 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 345 | 0.040 |
Why?
|
| DNA | 1 | 2022 | 1309 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1944 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1266 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 776 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 5344 | 0.020 |
Why?
|
| STAT1 Transcription Factor | 1 | 2010 | 53 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 78 | 0.020 |
Why?
|
| Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 2009 | 2 | 0.020 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2009 | 17 | 0.020 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 2009 | 14 | 0.020 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2009 | 9 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 333 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 421 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2008 | 27 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 8276 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2009 | 275 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 2331 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2884 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 3027 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 19252 | 0.010 |
Why?
|